Evolent Health, Inc. EVH Gain Loss On Sale Of Other Assets
Gain Loss On Sale Of Other Assets at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfOtherAssets.
The official record: Evolent Health, Inc.’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s gain loss on sale of other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s gain loss on sale of other assets?
- Evolent Health, Inc. (EVH) reported gain loss on sale of other assets of $3.72M in Q4 2025.
- What does gain loss on sale of other assets mean?
- This metric captures the net profit or loss realized from the disposal of non-core assets, such as property, equipment, or intangible assets, excluding inventory. It indicates the efficiency of capital recycling and the ability of management to monetize assets that no longer align with the company's strategic objectives. Significant gains or losses are often treated as non-recurring items in financial analysis.